Literature DB >> 28670675

Transurethral Resection of a Large Urinary Bladder Leiomyoma: A Rare Case Report.

Alper Gok1.   

Abstract

Bladder leiomyoma constitutes less than 0.5% of all bladder tumors. Until now, there have been about 250 case reports of bladder leiomyoma. We present a case of large bladder leiomyoma, that was treated successfully with transurethral resection. The patient presented to our clinic with both obstructive and irritative urinary complaints. Cystoscopy showed a mass lesion completely obstructing the bladder neck at the junction of right lateral wall and floor, which did not extend to ureteral orifices. A transurethral resection was performed at the same sessionof cystoscopy. At the postoperative 3rd month control visit, the patient's obstructive symptoms were completely healed but her irritative symptoms continued. A repeat cystoscopy revealed residual tumoral tissue remaining at the floor of the previous surgical area. Transurethral resection was performed, and these tissues were completely resected. At the control visit that was 3 months after the second transurethral resection procedure, the patient was free from any urinary complaints. In conclusion, large bladder leiomyomas can be treated successfully with endoscopic approaches.

Entities:  

Mesh:

Year:  2017        PMID: 28670675

Source DB:  PubMed          Journal:  Urol J        ISSN: 1735-1308            Impact factor:   1.510


  3 in total

1.  Paraurethral mass: A case of urethral leiomyoma surgical approach.

Authors:  Ashley N Matthew; Lauren N Siff
Journal:  Int Urogynecol J       Date:  2022-03-21       Impact factor: 1.932

Review 2.  Rare symptomatic bladder leiomyoma: case report and literature review.

Authors:  Liang He; Shengxian Li; Chao Zheng; Chunxi Wang
Journal:  J Int Med Res       Date:  2018-02-13       Impact factor: 1.671

3.  Transurethral resection of a bladder trigone leiomyoma: a rare case report.

Authors:  Athanasios Zachariou; Maria Filiponi; Fotios Dimitriadis; Aris Kaltsas; Nikolaos Sofikitis
Journal:  BMC Urol       Date:  2020-10-07       Impact factor: 2.264

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.